Mary Bach, MD, PharmD
Clinical Associate Professor
Division of Rheumatology
Sites of Practice: 
VA Puget Sound

Faculty Information

Biography
Education & Training: 
Pharm.D. and Certificate in Geriatric Pharmacy
University of Washington School of Pharmacy
Seattle WA
2002
M.D.
University of Washington School of Medicine
Seattle WA
2007
Internal Medicine Residency
Providence St. Vincent Medical Center
Portland, OR
2007-2010
Fellowship in Rheumatology
University of Washington Medical Center
Seattle WA
2010-2012
Contact
Email: 
Phone: 
(206) 768-5350
Research & Clinical Interests
Research Interests: 

Gut microbiome and its influence on autoimmune diseases.

Publications
Publications: 

Selected-

Lin P, Bach M, Asquith M, Lee AY, Akileswaran L, Stauffer P, Davin S, Pan Y, Cambronne ED, Dorris M, Debelius JW, Lauber CL, Ackermann G,Baeza YV, Gill T, Knight R, Colbert RA, Taurog JD, Van Gelder RN, Rosenbaum JT. HLA-B27 and Human β2-Microglobulin Affect the Gut Microbiota of Transgenic Rats. PLoS One. 2014 Aug 20;9(8):e105684. doi: 10.1371/journal.pone.0105684. eCollection 2014. *co-first author

Bach MH, Simkin PA. Uricosuric drugs: the once and future therapy for hyperuricemia?. Curr Opin Rheumatol. 2014 Mar;26(2):169-75.

Bach MH, Sadoun E, Reed MJ. Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging. Mech Ageing Dev, 2005 Apr;126(4):467-73.

Hazlet TK and Bach MH. The internet, confidentiality, and the pharmacy.coms. Camb Q Healthc Ethics. 2001 Spring;10(2):157-60.